Knight Therapeutics Inc.

GUD.TOTSXHealthcare● Active

$9.06

+$0.45(+5.23%)

Market Cap$888194423

P/E Ratio—

52W High$8.91

52W Low$5.66

Avg Volume87K

Open$8.50

Beta0.07

Cash on Hand Financials Revenue

Knight Therapeutics Inc. (GUD.TO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

GUD.TO · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$95.3M▼ -44.9% vs prior year

FY · as of Dec 31, 2025 · Reported in CAD

Cash & Cash Equiv. (CCE)

$76.4M

cashAndCashEquivalents

Short-Term Investments

$18.8M

shortTermInvestments

YoY Change vs Prior Year

-44.9%

vs prior fiscal year

Latest Quarter

$127.3M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in CAD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$95.3MCash on Hand

Total Debt$77.9MTotal Debt

Net Cash / Net Debt+$17.4MNet Cash Position

Cash vs Debt Ratio

Cash 55%Knight Therapeutics Inc. cash as % of market cap: 10.73%% · MCap $1BDebt 45%

Knight Therapeutics Inc. has a net cash position of $17.4M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$95.3M − $77.9M = +$17.4M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

GUD.TO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

GUD.TO cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$95.3M-44.9%

Dec 31, 2024FY$172.8M+11.9%

Dec 31, 2023FY$154.4M-16.8%

Dec 31, 2022FY$185.6M+13.9%

Dec 31, 2021FY$163.0M-60.4%

GUD.TO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

GUD.TO vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Knight Therapeutics Inc.YOU

GUD.TO

$95.3M$872M10.9%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Knight Therapeutics Inc. (GUD.TO) cash on hand as of December 31, 2025 is $95.3M, comprising $76.4M in cash and cash equivalents (CCE) plus $18.8M in short-term investments — reported as Knight Therapeutics Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Knight Therapeutics Inc. cash reserves or cash position.

Knight Therapeutics Inc. annual cash on hand history shows decreased -44.9% in 2025: decreased -44.9% in 2025. Knight Therapeutics Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Knight Therapeutics Inc. carries total debt of $77.9M against cash of $95.3M, resulting in a net cash position of +$17.4M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

GUD.TO cash on hand · 5 questions

As of December 31, 2025, Knight Therapeutics Inc. (GUD.TO) has $95,283,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $76,449,000 in cash and cash equivalents (CCE) plus $18,834,000 in short-term investments. Latest quarter (March 31, 2026): $127,290,000. Data sourced from the annual 10-K filing via FMP.

GUD.TO cash on handGUD.TO cash reservesGUD.TO cash 2025how much cash does GUD.TO have

▸ Source: FMP /balance-sheet-statement · US GAAP · Knight Therapeutics Inc. · Knight Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025